How To Get The MOST Out Of Stem Cells! A Deep Dive With Dr. Joy Kong

Dr. Kong personally undergoes IV umbilical cord stem cell infusions every three months, a practice she has maintained for eight years. Her rationale is rooted in scientific observations from animal studies where regular IV stem cell treatments extended both lifespan and health span by 30%. These studies showed animals with shinier fur, straighter spines, improved cognition, and, upon dissection, a return of growth factor levels, neurotransmitter levels, and senescent markers to those found in younger animals. She believes this indicates a physiological reversion to a younger state. The goal is to counteract the natural decline in mesenchymal stem cell (MSC) numbers that occurs with aging, which she illustrates with a dramatic 'cliff' analogy: from 1 in 10,000 cells at birth to 1 in 2 million by age 80. By regularly replenishing these cells, she aims to prevent the acceleration of aging, reduce inflammation, and maintain overall health.

Dr. Kong incorporates ozone therapy as a preparatory step before stem cell procedures. The process involves drawing a patient's blood, mixing it with ozone gas (O3), and then reinfusing it. She explains that 100% oxygen is passed through an ozonator, converting about 2% into O3, with the rest remaining O2. When this mixture is combined with blood, it profoundly super-oxygenates it. The O3 quickly breaks down into O2, releasing 'ozonites' – molecules with potent immune-boosting, antiviral, antibacterial, and anti-cancer properties. She notes that ozone activates the body's intrinsic antioxidant system, rather than just supplying external antioxidants. Additionally, it makes red blood cells more flexible, allowing for better oxygen delivery throughout the body. This comprehensive effect is intended to enhance the body's natural reparative mechanisms, thereby improving the overall results of subsequent stem cell treatments.

Dr. Kong integrates photobiomodulation, or laser therapy, into her treatment protocols, particularly in conjunction with stem cell infusions. She explains that the laser has different settings, including a 'pre-stem cell setting,' which uses specific frequencies to prepare the body. The primary goal is to make cells, including stem cells, more mobile and energetic. She cites a study where mice with induced heart attacks, after having light shone on their legs, showed a 25-fold increase in stem cell density in their hearts compared to controls. This suggests that the laser doesn't need to be directly on the target organ but can activate cells systemically. Furthermore, by concentrating the light on specific organs while stem cells are circulating, she believes it can help direct these cells to areas requiring repair. She views this as an early stage of 'energy medicine,' where light acts as a powerful tool to communicate with and activate cellular processes.

Dr. Kong is a strong proponent of peptide therapy, using it both in her clinic via infusions and providing it for at-home injections. She particularly likes peptides for their ability to target specific issues and provide a multitude of benefits across different organ systems. For instance, she combines BPC-157 and TB-500 with stem cells due to their broad effects on brain, immune, musculoskeletal, and cardiovascular health. She also utilizes growth hormone-releasing peptides like CJC-1295 and Ipamorelin (or Tesamorelin) for muscle building, fat reduction, and general regeneration, including brain health. T-alpha 1 is favored for autoimmune conditions and immune boosting. For brain-specific benefits, she mentions Selank for anxiety and Semax for cognitive repair. She views peptides as a way to replenish declining natural signaling molecules as we age, noting that while thousands exist, only a fraction have been discovered. A standout is Epitalon, which she recommends for 15 days every six months, citing a study where it led to a nine-year younger cardiovascular system and reduced mortality from cardiovascular disease over a decade.

Dr. Kong is a strong proponent of ketamine IV treatments, particularly for conditions like treatment-resistant depression and PTSD. She notes that ketamine is FDA-approved for the former and is remarkably effective at rapidly alleviating depressive symptoms, a speed of action she compares only to electroconvulsive therapy (ECT). The recommended protocol involves six sessions within the first two to three weeks to facilitate neural rewiring. This rapid effect is attributed to ketamine's ability to drastically increase brain-derived neurotrophic factor (BDNF) and promote the formation of new synapses, essentially helping to 'rewire' the brain. She emphasizes its power for PTSD, acknowledging that stem cells alone would be insufficient to address such complex neurological wiring issues, suggesting ketamine taps into a deeper, potentially 'quantum' level of healing.

Dr. Kong advocates for an integrative medicine approach as the future of healthcare, emphasizing that it should be foundational to all medical specialties. She defines it as looking at the body as a complex, interconnected entity where factors like nutrition, the microbiome, and hormones have widespread effects across multiple organs. Instead of immediately prescribing drugs for symptoms, this approach seeks to identify and address the root causes of illness. She believes that all medical schools should teach this 'integrative medicine language,' ensuring that practitioners are fluent in understanding how these fundamental elements impact health. By fixing these foundations first, not only is overall patient health improved, but any subsequent specialized interventions (like surgery or heavy-duty drugs) become more effective because the patient's body is in a better state to heal and respond.

Dr. Kong, despite being board-certified in psychiatry, found the field's reliance on medication to be myopic and limited. She observed that while drugs like SSRIs and antipsychotics could be powerful and life-saving in emergency situations (e.g., preventing suicide or harm), they failed to address the fundamental reasons why individuals developed conditions like bipolar disorder, schizophrenia, or depression. She felt that psychiatry primarily focused on receptor manipulation and neurotransmitter levels without investigating deeper issues such as nutritional deficiencies, hormonal imbalances, toxic exposures, or microbiome health. This drug-centric model, she argues, prioritizes diagnosis to justify prescriptions rather than seeking comprehensive, long-term solutions.

Dr. Kong conducted extensive research into different stem cell sources to determine the 'best' option for her patients. Her findings consistently pointed to umbilical cord stem cells as superior to those derived from a person's own fat or bone marrow. She cites evidence showing umbilical cord cells excel in anti-inflammatory actions, neuroprotective effects, remaining generations (how many times they can divide), differentiation potentials (what types of cells they can become), and telomere length. She explains that a person's own cells carry the 'burdens' of their age and environmental exposures, leading to decline in number and vitality over time, similar to the decline in sperm and egg quality with age. Umbilical cord cells, being 'neutral' and from a young, healthy donor, bypass these issues and do not typically evoke an immune response.

Stem cell expansion involves culturing cells in a lab to multiply them, which can significantly reduce costs. However, Dr. Kong explains that this process carries substantial risks. By the fourth generation (passage), there's significant deterioration, and even with just one passage, genetic changes and degradation can occur. Crucially, expanded cells can start expressing surface markers of the donor, which can trigger an immune response in the recipient, leading to adverse effects like 'cytokine storms' that Tony Robbins reportedly experienced. This is a major reason why she believes people going overseas for expanded cells often experience side effects. She contrasts this with the 'blank' nature of unexpanded umbilical cord cells that typically do not provoke an immune reaction.

Dr. Kong explains that the FDA's current regulatory framework views stem cells as drugs if they are not performing their 'original' function (e.g., an umbilical cord acting as a conduit). If stem cells are extracted from the cord and used for therapeutic purposes, the FDA argues they are no longer functioning as a conduit, thus classifying them as drugs. This classification would force stem cell therapies to undergo the same rigorous, multi-phase, and extremely expensive drug approval process (estimated at $2.1 billion per drug) that pharmaceutical companies endure. This financial burden is prohibitive for most tissue banks and smaller entities, leading to bankruptcies and severely restricting the availability of these therapies. Dr. Kong questions the FDA's authority to define the 'function' of these cells, especially given the evolving scientific understanding of their capabilities.